Back to the main directory
EarningsReview / Equity
- AAK - Operational excellence despite market headwinds by Danske Bank Equity Research
- On the Road by BNP Paribas Exane
- Prices, volumes, arbitrage opportunities, and implications on company profits by BNP Paribas Exane
- The Speciality Foundry by BNP Paribas Exane
- Now or never … ? by BNP Paribas Exane
- 3Q25 post view: Short term headwinds vs controlled indebtedness by BNP Paribas Exane
- Patiently waiting by BNP Paribas Exane
- Tietoevry - Margin recovery underway, growth headwinds prevail by Danske Bank Equity Research
- Running It Hot - Life After 1.5C by BNP Paribas Exane
- Q3'25 results: Beats and achieves record profitability by BNP Paribas Exane
- Invisio - Looking to land some bigger fish by Danske Bank Equity Research
- 3Q25 First Take: Headline & Underlying Miss by BNP Paribas Exane
- Dynavox - Sticking to our guns by Danske Bank Equity Research
- SEB - Corporate momentum and balance sheet command by Danske Bank Equity Research
- Terveystalo - Despite easier comparables, profit warning risk in Q4 by Danske Bank Equity Research
- Returning to positive growth in Q3 by BNP Paribas Exane
- Brown case: dismissed by BNP Paribas Exane
- 3Q25 first take: EBIT 4% beat a modest relief by BNP Paribas Exane
- Revenue model pivot in focus by BNP Paribas Exane
- Q3 beat, guidance unchanged, margin outlook improves by BNP Paribas Exane
- Distributing more - buyback raised €300m by BNP Paribas Exane
- VINCI: VENTAS 3T’25 (ANÁLISIS BANCO SABADELL) by Sabadell
- INVEST SECURITIES - ALTEN : T3 sans surprise, RDV confirmé pour début 2026 - ACHAT, OC 136€ by Invest Securities
- LISI - Une excellente publication by MidCap Partners
- Roche Bobois - Un T3 en baisse, comme attendu by MidCap Partners